MBX vs VRTX: Which Stock is Better?

Side-by-side comparison of Mbx Biosciences Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

MBX

Mbx Biosciences Inc

$28.00

VRTX

Vertex Pharmaceuticals Inc

$469.34

Key Metrics Comparison

MetricMBXVRTXWinner
Market Cap$1.26B$119.21BVRTX
P/E Ratio3.6530.68MBX
EPS (TTM)$7.67$15.30VRTX
Revenue Growth0.0%0.1%VRTX
Gross Margin0.0%53.7%VRTX

Analyze MBX

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MBX or VRTX a better investment?

Comparing MBX and VRTX: Mbx Biosciences Inc has a market cap of $1.26B while Vertex Pharmaceuticals Inc has $119.21B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MBX and VRTX?

MBX (Mbx Biosciences Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MBX or VRTX?

Based on P/E ratios, MBX trades at a lower multiple (3.7x vs 30.7x).

Which is growing faster: MBX or VRTX?

VRTX has higher revenue growth at 0.1% vs 0.0% for MBX.

Which company is more profitable: MBX or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for MBX.

Which is the larger company: MBX or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $119.21B compared to $1.26B for MBX.

Should I buy MBX or VRTX in 2026?

Both MBX and VRTX have investment merit. MBX trades at $28.00 while VRTX trades at $469.34. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MBX and VRTX stock?

Key differences: Market Cap ($1.26B vs $119.21B), P/E Ratio (3.7x vs 30.7x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).

Popular Stock Comparisons